In U.S.
Dr Reddys Laboratories announced that it has launched Memantine Hydrochloride Tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of Namenda (memantine HCI) tablets in the US market on 12 July 2015 approved by the United States Food & Administration (USFDA).The Namenda (memantine HCI) tablets brand has US sales of approximately $1.4 billion MAT for the most recent twelve months ending in May 2015 according to IMS Health.
Powered by Capital Market - Live News
